161 related articles for article (PubMed ID: 26707703)
1. Interrogating Circulating Microsomes and Exosomes Using Metal Nanoparticles.
Zhou YG; Mohamadi RM; Poudineh M; Kermanshah L; Ahmed S; Safaei TS; Stojcic J; Nam RK; Sargent EH; Kelley SO
Small; 2016 Feb; 12(6):727-32. PubMed ID: 26707703
[TBL] [Abstract][Full Text] [Related]
2. Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer.
Duijvesz D; Versluis CY; van der Fels CA; Vredenbregt-van den Berg MS; Leivo J; Peltola MT; Bangma CH; Pettersson KS; Jenster G
Int J Cancer; 2015 Dec; 137(12):2869-78. PubMed ID: 26139298
[TBL] [Abstract][Full Text] [Related]
3. Tumor Microenvironment Modulation via Gold Nanoparticles Targeting Malicious Exosomes: Implications for Cancer Diagnostics and Therapy.
Roma-Rodrigues C; Raposo LR; Cabral R; Paradinha F; Baptista PV; Fernandes AR
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098821
[TBL] [Abstract][Full Text] [Related]
4. Highly specific electrochemical analysis of cancer cells using multi-nanoparticle labeling.
Wan Y; Zhou YG; Poudineh M; Safaei TS; Mohamadi RM; Sargent EH; Kelley SO
Angew Chem Int Ed Engl; 2014 Nov; 53(48):13145-9. PubMed ID: 25283158
[TBL] [Abstract][Full Text] [Related]
5. Magneto-Mediated Electrochemical Sensor for Simultaneous Analysis of Breast Cancer Exosomal Proteins.
An Y; Li R; Zhang F; He P
Anal Chem; 2020 Apr; 92(7):5404-5410. PubMed ID: 32157871
[TBL] [Abstract][Full Text] [Related]
6. Proteomic Profiling of Serum-Derived Exosomes from Ethnically Diverse Prostate Cancer Patients.
Turay D; Khan S; Diaz Osterman CJ; Curtis MP; Khaira B; Neidigh JW; Mirshahidi S; Casiano CA; Wall NR
Cancer Invest; 2016; 34(1):1-11. PubMed ID: 26536157
[TBL] [Abstract][Full Text] [Related]
7. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells.
Saari H; Lázaro-Ibáñez E; Viitala T; Vuorimaa-Laukkanen E; Siljander P; Yliperttula M
J Control Release; 2015 Dec; 220(Pt B):727-37. PubMed ID: 26390807
[TBL] [Abstract][Full Text] [Related]
8. Cancer Exosomes as Mediators of Drug Resistance.
André Mdo R; Pedro A; Lyden D
Methods Mol Biol; 2016; 1395():229-39. PubMed ID: 26910077
[TBL] [Abstract][Full Text] [Related]
9. Quantification of Exosomes.
Koritzinsky EH; Street JM; Star RA; Yuen PS
J Cell Physiol; 2017 Jul; 232(7):1587-1590. PubMed ID: 27018079
[TBL] [Abstract][Full Text] [Related]
10. Exosomal particles secreted by prostate cancer cells are potent mRNA and protein vehicles for the interference of tumor and tumor environment.
Rauschenberger L; Staar D; Thom K; Scharf C; Venz S; Homuth G; Schlüter R; Brandenburg LO; Ziegler P; Zimmermann U; Weitschies W; Völker U; Lendeckel U; Walther R; Burchardt M; Stope MB
Prostate; 2016 Mar; 76(4):409-24. PubMed ID: 26643154
[TBL] [Abstract][Full Text] [Related]
11. Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage.
Rupp AK; Rupp C; Keller S; Brase JC; Ehehalt R; Fogel M; Moldenhauer G; Marmé F; Sültmann H; Altevogt P
Gynecol Oncol; 2011 Aug; 122(2):437-46. PubMed ID: 21601258
[TBL] [Abstract][Full Text] [Related]
12. Lectin-induced agglutination method of urinary exosomes isolation followed by mi-RNA analysis: Application for prostate cancer diagnostic.
Samsonov R; Shtam T; Burdakov V; Glotov A; Tsyrlina E; Berstein L; Nosov A; Evtushenko V; Filatov M; Malek A
Prostate; 2016 Jan; 76(1):68-79. PubMed ID: 26417675
[TBL] [Abstract][Full Text] [Related]
13. Integrin β4 and vinculin contained in exosomes are potential markers for progression of prostate cancer associated with taxane-resistance.
Kawakami K; Fujita Y; Kato T; Mizutani K; Kameyama K; Tsumoto H; Miura Y; Deguchi T; Ito M
Int J Oncol; 2015 Jul; 47(1):384-90. PubMed ID: 25997717
[TBL] [Abstract][Full Text] [Related]
14. Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches.
Zarovni N; Corrado A; Guazzi P; Zocco D; Lari E; Radano G; Muhhina J; Fondelli C; Gavrilova J; Chiesi A
Methods; 2015 Oct; 87():46-58. PubMed ID: 26044649
[TBL] [Abstract][Full Text] [Related]
15. miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.
Corcoran C; Rani S; O'Driscoll L
Prostate; 2014 Sep; 74(13):1320-34. PubMed ID: 25053345
[TBL] [Abstract][Full Text] [Related]
16. Cascade Signal Amplification Based on Copper Nanoparticle-Reported Rolling Circle Amplification for Ultrasensitive Electrochemical Detection of the Prostate Cancer Biomarker.
Zhu Y; Wang H; Wang L; Zhu J; Jiang W
ACS Appl Mater Interfaces; 2016 Feb; 8(4):2573-81. PubMed ID: 26765624
[TBL] [Abstract][Full Text] [Related]
17. First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications.
Miller IV; Raposo G; Welsch U; Prazeres da Costa O; Thiel U; Lebar M; Maurer M; Bender HU; von Luettichau I; Richter GH; Burdach S; Grunewald TG
Biol Cell; 2013 Jul; 105(7):289-303. PubMed ID: 23521563
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating cancer cells using electrocatalytic gold nanoparticles.
Maltez-da Costa M; de la Escosura-Muñiz A; Nogués C; Barrios L; Ibáñez E; Merkoçi A
Small; 2012 Dec; 8(23):3605-12. PubMed ID: 22893274
[TBL] [Abstract][Full Text] [Related]
19. Isolation of prostate cancer-related exosomes.
Mizutani K; Terazawa R; Kameyama K; Kato T; Horie K; Tsuchiya T; Seike K; Ehara H; Fujita Y; Kawakami K; Ito M; Deguchi T
Anticancer Res; 2014 Jul; 34(7):3419-23. PubMed ID: 24982349
[TBL] [Abstract][Full Text] [Related]
20. Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer.
Kato T; Mizutani K; Kameyama K; Kawakami K; Fujita Y; Nakane K; Kanimoto Y; Ehara H; Ito H; Seishima M; Deguchi T; Ito M
Urol Oncol; 2015 Sep; 33(9):385.e15-20. PubMed ID: 26027763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
